Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    0.00 (0.00%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £1.37m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

ValiRx News

ValiRx subsidiary Inaphaea agrees exclusive PredictRx licensing deal
4 Aug 2025

ValiRx subsidiary Inaphaea agrees exclusive PredictRx licensing deal

(Alliance News) - ValiRx PLC on Monday said subsidiary Inaphaea BioLabs has agreed an exclusive licensing deal with Dominion Biotech Ltd for Inaphaea'...

CORRECT: Stocks rise, UK data paints "gloomy" picture
20 Jun 2025

CORRECT: Stocks rise, UK data paints "gloomy" picture

(Corrects the name of the AJ Bell analyst quoted.)

Ambrose exercises ValiRx oncology option worth up to £16m
20 Jun 2025

Ambrose exercises ValiRx oncology option worth up to £16m

(Sharecast News) - ValiRx confirmed on Friday that Ambrose Healthcare has exercised its option to license the VAL401 oncology asset, in a deal worth u...

LONDON MARKET MIDDAY: Stocks rise, UK data paints "gloomy" picture
20 Jun 2025

LONDON MARKET MIDDAY: Stocks rise, UK data paints "gloomy" picture

(Alliance News) - Stock prices in London were higher at midday on Friday, amid a slight lull in tensions over the Israel-Iran conflict after US Presid...

ValiRx signs licence with Ambrose worth GBP16 million plus royalties
20 Jun 2025

ValiRx signs licence with Ambrose worth GBP16 million plus royalties

(Alliance News) - ValiRx PLC shares surged on Friday as it said Ambrose Healthcare Ltd has exercised its option to licence its VAL401 asset for GBP16 ...

ValiRx subsidiary enters evaluation agreement with Omios Biologics
3 Jun 2025

ValiRx subsidiary enters evaluation agreement with Omios Biologics

(Alliance News) - ValiRx PLC on Tuesday said subsidiary Cytolytix Ltd has entered an evaluation and material transfer agreement with California-based ...

IN BRIEF: ValiRx extends agreement with Dominion Biotech
12 May 2025

IN BRIEF: ValiRx extends agreement with Dominion Biotech

ValiRx PLC - Essex-based life sciences company focusing on early-stage cancer therapeutics and women's health - signs an extension to the evaluation a...

TRADING UPDATES: Strategic Minerals sales up; 4Global wins contract
4 Apr 2025

TRADING UPDATES: Strategic Minerals sales up; 4Global wins contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: